Healthcare / Medical Care FacilitiesSES
$0.16
+0.00 (+2.50%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 26% · confianza 25%
FCF escenarios
weak_data · normalized FCF $1.1M · quality 46.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
68/100
B
Piotroski
8/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$34M
P/E
16.4x
↓EV/EBITDA
5.2x
↓ROE
6.3%
↑Gross Margin
74.2%
↑Debt/Equity
0.73
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2022–2025 · 3 años de histórico normalizado
Revenue CAGR
+12.1%
FCF CAGR
-24.0%
FCF margin
5.3%
FCF / Net income
2.70x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $77.1M · net income $1.5M · FCF $4.1M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $77.1M | $77.1M | $68.0M | $58.0M | $54.8M |
| Net Income | $1.5M | $1.5M | $719752.00 | $2.1M | $3.1M |
| EBITDA | $6.7M | $6.7M | $4.9M | $5.4M | $8.0M |
| EPS | 0.01 | 0.01 | 0.00 | 0.01 | 0.01 |
| Gross Margin | 74.2% | 74.2% | 70.9% | 68.5% | 71.4% |
| Operating Margin | 11.1% | 11.1% | 8.5% | 11.4% | 14.1% |
| Net Margin | 2.0% | 2.0% | 1.1% | 3.6% | 5.7% |
| Balance Sheet | |||||
| Debt/Equity | 0.73 | 0.73 | 0.92 | 0.60 | 0.39 |
| Current Ratio | 1.17 | 1.17 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $4.1M | $4.1M | $1.1M | $173567.00 | $9.4M |
| Returns | |||||
| ROE | 6.3% | 6.3% | 3.2% | 9.2% | 14.1% |
| Valuation | |||||
| P/E | 16.40 | 16.40 | 38.57 | 17.65 | 11.40 |
| EV/EBITDA | 5.22 | 5.22 | 6.12 | 5.82 | 2.93 |
| P/B | 1.39 | 1.39 | 1.22 | 1.62 | 1.60 |
| Growth & Yield | |||||
| Revenue Growth | 13.4% | 13.4% | 17.2% | 5.9% | — |
| EPS Growth | 111.4% | 111.4% | -65.7% | -32.0% | — |
| Dividend Yield | 0.6% | 0.6% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
25.3%
EPS terminal req.
$0.01
Spread vs growth
86.1%
5Y implied EPS CAGR
18.9%
EPS terminal req.
$0.02
Spread vs growth
92.5%
10Y implied EPS CAGR
14.4%
EPS terminal req.
$0.03
Spread vs growth
97.0%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
+63.0%
Start / end P/E
28.9x → 22.2x
EPS bridge
0.00 → 0.01
Residual
-25.9%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.